A depot-forming glucagon-like peptide-1 fusion protein reduces blood glucose for five days with a single injection M Amiram, KM Luginbuhl, X Li, MN Feinglos, A Chilkoti Journal of controlled release 172 (1), 144-151, 2013 | 135 | 2013 |
A brush-polymer/exendin-4 conjugate reduces blood glucose levels for up to five days and eliminates poly (ethylene glycol) antigenicity Y Qi, A Simakova, NJ Ganson, X Li, KM Luginbuhl, I Ozer, W Liu, ... Nature biomedical engineering 1 (1), 0002, 2016 | 132 | 2016 |
Injectable protease-operated depots of glucagon-like peptide-1 provide extended and tunable glucose control M Amiram, KM Luginbuhl, X Li, MN Feinglos, A Chilkoti Proceedings of the National Academy of Sciences 110 (8), 2792-2797, 2013 | 127 | 2013 |
One-week glucose control via zero-order release kinetics from an injectable depot of glucagon-like peptide-1 fused to a thermosensitive biopolymer KM Luginbuhl, JL Schaal, B Umstead, EM Mastria, X Li, S Banskota, ... Nature biomedical engineering 1 (6), 0078, 2017 | 112 | 2017 |
Genetically encoded lipid–polypeptide hybrid biomaterials that exhibit temperature-triggered hierarchical self-assembly D Mozhdehi, KM Luginbuhl, JR Simon, M Dzuricky, R Berger, HS Varol, ... Nature chemistry 10 (5), 496-505, 2018 | 88 | 2018 |
Recombinant synthesis of hybrid lipid–peptide polymer fusions that self‐assemble and encapsulate hydrophobic drugs KM Luginbuhl, D Mozhdehi, M Dzuricky, P Yousefpour, FC Huang, ... Angewandte Chemie International Edition 56 (45), 13979-13984, 2017 | 68 | 2017 |
Controlled release of biologics for the treatment of type 2 diabetes CA Gilroy, KM Luginbuhl, A Chilkoti Journal of Controlled Release 240, 151-164, 2016 | 61 | 2016 |
Quantitative proteomics identifies vasopressin-responsive nuclear proteins in collecting duct cells LK Schenk, SJ Bolger, K Luginbuhl, PA Gonzales, MM Rinschen, MJ Yu, ... Journal of the American Society of Nephrology 23 (6), 1008-1018, 2012 | 60 | 2012 |
Genetically encoded cholesterol-modified polypeptides D Mozhdehi, KM Luginbuhl, M Dzuricky, SA Costa, S Xiong, FC Huang, ... Journal of the American Chemical Society 141 (2), 945-951, 2019 | 40 | 2019 |
Ultrasensitive point-of-care immunoassay for secreted glycoprotein detects Ebola infection earlier than PCR CM Fontes, BD Lipes, J Liu, KN Agans, A Yan, P Shi, DF Cruz, G Kelly, ... Science translational medicine 13 (588), eabd9696, 2021 | 24 | 2021 |
Design of Sequence‐Specific Polymers by Genetic Engineering D Mozhdehi, KM Luginbuhl, S Roberts, A Chilkoti Sequence‐Controlled Polymers, 91-115, 2018 | 4 | 2018 |
494 Pisitkun T, and Knepper MA LK Schenk, SJ Bolger, K Luginbuhl, PA Gonzales, MM Rinschen, MJ Yu, ... Quantitative proteomics identifies vasopressin-responsive 495, 1008-1018, 0 | 4 | |
Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly A Chilkoti, D Mozhdehi, KM Luginbuhl US Patent 11,648,200, 2023 | 2 | 2023 |
Genetically encoded polypeptide for affinity capture and purification of biologics KM Luginbuhl, A Chilkoti US Patent App. 17/268,314, 2021 | 2 | 2021 |
Genetically encoded polypeptide for affinity capture and purification of biologics KM Luginbuhl, A Chilkoti US Patent 11,739,126, 2023 | 1 | 2023 |
IsoTag™ AAV: an innovative, scalable & non-chromatographic method for streamlined AAV manufacturing J Haley, JB Jones, S Petraki, M Callander, S Shrestha, E Springfield, ... Cell & gene therapy insights 8 (10), 1287, 2022 | 1 | 2022 |
Compositions and methods for improving lentiviral transduction N Votaw, M Dzuricky, KM Luginbuhl US Patent App. 18/351,209, 2024 | | 2024 |
Genetically encoded polypeptide for affinity capture and purification of biologics KM Luginbuhl, A Chilkoti US Patent App. 18/346,456, 2024 | | 2024 |
Compositions comprising aav-binding polypeptides and methods of using the same KM Luginbuhl, L Hyun, M Dzuricky US Patent App. 18/309,154, 2023 | | 2023 |
Purification matrices comprising aav-binding polypeptides and methods of using the same KM Luginbuhl, M Dzuricky, Z Elmore, A Asokan US Patent App. 17/800,700, 2023 | | 2023 |